| Primary |
| Gastrooesophageal Reflux Disease |
20.4% |
| Reflux Oesophagitis |
8.9% |
| Helicobacter Infection |
7.6% |
| Gastritis |
7.0% |
| Hypertension |
6.4% |
| Barrett's Oesophagus |
5.7% |
| Asthma |
4.5% |
| Dyspepsia |
4.5% |
| Epilepsy |
4.5% |
| Gastric Ulcer |
4.5% |
| Oesophagitis |
4.5% |
| Ulcer |
3.2% |
| Blood Pressure |
2.5% |
| Depression |
2.5% |
| Gastritis Atrophic |
2.5% |
| Gastrointestinal Disorder |
2.5% |
| Reflux Gastritis |
2.5% |
| Appendicitis Perforated |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Cardiovascular Disorder |
1.9% |
|
| Tetany |
9.7% |
| Vomiting |
9.7% |
| Weight Decreased |
8.1% |
| Hypomagnesaemia |
6.5% |
| Hypoparathyroidism |
6.5% |
| Urticaria |
6.5% |
| Drug Exposure During Pregnancy |
4.8% |
| Hearing Impaired |
4.8% |
| Nephritis Interstitial |
4.8% |
| Vision Blurred |
4.8% |
| Visual Disturbance |
4.8% |
| Enterocolitis Haemorrhagic |
3.2% |
| Gastric Ulcer |
3.2% |
| Haemorrhage |
3.2% |
| Joint Swelling |
3.2% |
| Oedema Peripheral |
3.2% |
| Off Label Use |
3.2% |
| Oxygen Saturation Decreased |
3.2% |
| Pain In Extremity |
3.2% |
| Pneumonia Aspiration |
3.2% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
18.2% |
| Gastritis |
11.7% |
| Hypertension |
9.3% |
| Prophylaxis |
7.7% |
| Drug Use For Unknown Indication |
6.8% |
| Gastric Ulcer |
6.8% |
| Reflux Oesophagitis |
6.2% |
| Helicobacter Infection |
4.6% |
| Gastritis Atrophic |
3.7% |
| Gastritis Prophylaxis |
3.7% |
| Anticoagulant Therapy |
2.8% |
| Vasodilation Procedure |
2.8% |
| Barrett's Oesophagus |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Abdominal Pain Upper |
1.9% |
| Appendicitis Perforated |
1.9% |
| Cardiac Disorder |
1.9% |
| Gastrointestinal Disorder |
1.9% |
| Sedative Therapy |
1.9% |
| Gastric Disorder |
1.5% |
|
| Tetany |
19.5% |
| Nephritis Interstitial |
11.0% |
| Venous Occlusion |
11.0% |
| Urticaria |
7.3% |
| Hypovitaminosis |
6.1% |
| Vomiting |
6.1% |
| Diarrhoea |
3.7% |
| Hearing Impaired |
3.7% |
| Hypomagnesaemia |
3.7% |
| Renal Disorder |
3.7% |
| Blood Chromogranin A Increased |
2.4% |
| Haemorrhage |
2.4% |
| Hyponatraemia |
2.4% |
| Hypoparathyroidism |
2.4% |
| Non-small Cell Lung Cancer Stage Iiib |
2.4% |
| Oedema Peripheral |
2.4% |
| Off Label Use |
2.4% |
| Sleep Disorder |
2.4% |
| Tetanus |
2.4% |
| Toxic Epidermal Necrolysis |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
39.9% |
| Hypertension |
8.3% |
| Product Used For Unknown Indication |
8.2% |
| Rheumatoid Arthritis |
7.8% |
| Crohn's Disease |
5.9% |
| Pain |
3.6% |
| Prophylaxis |
2.8% |
| Osteoporosis |
2.7% |
| Depression |
2.5% |
| Diabetes Mellitus |
2.3% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Hiv Infection |
1.9% |
| Asthma |
1.8% |
| Atrial Fibrillation |
1.6% |
| Non-small Cell Lung Cancer |
1.5% |
| Anxiety |
1.4% |
| Colitis Ulcerative |
1.4% |
| Gastric Cancer |
1.4% |
| Constipation |
1.4% |
| Insomnia |
1.3% |
|
| Vomiting |
13.4% |
| Weight Decreased |
11.1% |
| Pneumonia |
9.2% |
| Thrombocytopenia |
6.9% |
| Sepsis |
6.5% |
| Tachycardia |
5.1% |
| Upper Gastrointestinal Haemorrhage |
5.1% |
| Urinary Tract Infection |
4.6% |
| Nausea |
4.1% |
| Wheezing |
4.1% |
| Tremor |
3.7% |
| Vaginal Haemorrhage |
3.7% |
| Pyrexia |
3.2% |
| Renal Failure |
3.2% |
| Intestinal Obstruction |
2.8% |
| Liver Function Test Abnormal |
2.8% |
| Oedema Peripheral |
2.8% |
| Visual Acuity Reduced |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Cellulitis |
2.3% |
|
